| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $647.4M | — | +24.8% |
| Cost of Revenue | $67.1M | — | +11.0% |
| Gross Profit | $580.3M | — | +26.6% |
| R&D Expense | $109.8M | — | +41.0% |
| SG&A Expense | $70.5M | — | +49.4% |
| Operating Income | $46.2M | — | +405.2% |
| Pre-tax Income | $53.9M | — | +272.0% |
| Income Tax | $455K | — | -70.7% |
| Net Income | $53.5M | — | +313.1% |
| EPS (Basic) | $0.14 | — | — |
| EPS (Diluted) | $0.13 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $607.7M | +30.3% | +91.0% |
| Accounts Receivable | $294.3M | +14.1% | — |
| Current Assets | $1.74B | -0.7% | — |
| Total Assets | $1.95B | -0.7% | — |
| Current Liabilities | $344.1M | -11.3% | — |
| Total Liabilities | $508.9M | -9.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $87.5M | — | +439.7% |
| Investing Cash Flow | $127.3M | — | +1799.8% |
| Financing Cash Flow | -$73.4M | — | — |
| — |
| Stockholders' Equity | $1.44B | +2.8% | +175.5% |